Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4269516 | 0.88 | MAPT (0.37) | LMNA | |
| SCHEMBL2692180 | 0.88 | MAPT (0.33) | — | |
| Cyclohexanone SCHEMBL29104416 | 0.84 | TRIM24 (0.37) | — | |
| SCHEMBL1678779 | 0.78 | — | — | |
| SCHEMBL7639721 | 0.78 | TRIM24 (0.37) | — | |
| SCHEMBL8045933 | 0.77 | MAPT (0.36) | — | |
| SCHEMBL11728621 | 0.77 | CRBN (0.33) | LMNA | |
| SCHEMBL2693212 | 0.77 | MAPT (0.37) | — | |
| SCHEMBL919239 | 0.77 | MAPT (0.33) | LMNA | |
| SCHEMBL8733282 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117986090-A | Novel fragrances with rose scent | 西姆莱斯股份公司 | 2024-05-07 | — | — | CN | claimed |
| US-11634659-B2 | Fragrances with rose scent | SYMRISE AG (DE) | 2023-04-25 | — | — | US | claimed |
| US-20210324300-A1 | NOVEL FRAGRANCES WITH ROSE SCENT | SYMRISE AG (DE) | 2021-10-21 | — | — | US | claimed |
| EP-3826986-A1 | NOVEL ODORANTS HAVING ROSE ODOUR | Symrise AG (DE) | 2021-06-02 | — | — | EP | claimed |
| CN-112469685-A | Novel flavoring agent with rose smell | 西姆莱斯股份公司 | 2021-03-09 | — | — | CN | claimed |
| WO-2020020434-A1 | NOVEL ODORANTS HAVING ROSE ODOUR | SYMRISE AG (DE) | 2020-01-30 | — | — | WO | claimed |
| WO-2007009982-A1 | 4-ISOAMYLCYCLOHEXANONE AS A PERFUME | SYMRISE GMBH & CO. KG (DE) | 2007-01-25 | — | — | WO | claimed |
| EP-3826986-B1 | NOVEL ODORANTS HAVING ROSE ODOUR | SYMRISE AG (DE) | 2026-03-04 | — | — | EP | disclosed |
| CN-117986090-A | Novel fragrances with rose scent | 西姆莱斯股份公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-112469685-B | Novel fragrances with rose scent | 西姆莱斯股份公司 | 2024-01-02 | — | — | CN | disclosed |
| US-11634659-B2 | Fragrances with rose scent | SYMRISE AG (DE) | 2023-04-25 | — | — | US | disclosed |
| US-20210324300-A1 | NOVEL FRAGRANCES WITH ROSE SCENT | SYMRISE AG (DE) | 2021-10-21 | — | — | US | disclosed |
| EP-3826986-A1 | NOVEL ODORANTS HAVING ROSE ODOUR | Symrise AG (DE) | 2021-06-02 | — | — | EP | disclosed |
| WO-2007009982-A1 | 4-ISOAMYLCYCLOHEXANONE AS A PERFUME | SYMRISE GMBH & CO. KG (DE) | 2007-01-25 | — | — | WO | disclosed |
| US-20040224926-A1 | Inhibitory or blocking agents of molecular generating and/or inducing functions | KOYAMA SHOZO (JP) | 2004-11-11 | — | — | US | disclosed |
| US-6710090-B2 | A CYCLOHEX-1-EN-2-ONE COMPOUND | KOYAMA SHOZO (JP) | 2004-03-23 | — | — | US | disclosed |
| US-20020165206-A1 | Inhibitory or blocking agents of molecular generating and/or inducing functions | KOYAMA SHOZO (JP) | 2002-11-07 | — | — | US | disclosed |
| US-6346551-B1 | ANTIBACTERIAL, ANTIFUNGAL, ANTIVIRAL, BACTERICIDAL AND/OR STERILIZATION AGENTS, ANTICANCER DRUGS, BLOOD COAGULATION AND FIBRINOLYSIS INHIBITORS AND/OR BLOCKING AGENTS, INHIBITORY AND/OR BLOCKING AGENTS OF ANTIGEN-ANTIBODY REACTIONS | KOYAMA SHOZO (JP) | 2002-02-12 | — | — | US | disclosed |
| EP-0780122-A1 | DEPRESSANT OF FUNCTIONS DEVELOPED BY MOLECULE | Koyama, Shozo (JP) | 1997-06-25 | — | — | EP | disclosed |
| US-4130502-A | Liquid crystalline cyclohexane derivatives | MERCK PATENT GESELLSCHAFT MIT (DE) | 1978-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11634659-B2 | Fragrances with rose scent | NR1H2, DUOX2, AOX1 | LMNA 3477/4885 |
| US-20210324300-A1 | NOVEL FRAGRANCES WITH ROSE SCENT | NR1H2, DUOX2, AOX1 | LMNA 3840/4885 |
| US-20020165206-A1 | Inhibitory or blocking agents of molecular generating and/or inducing functions | CD69, TFPI, SERPINE1 | LMNA 997/4885 |
| US-20040224926-A1 | Inhibitory or blocking agents of molecular generating and/or inducing functions | CD47, MCL1, CD74 | LMNA 4495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.